Sartorius Stedim Biotech S.A.

UNDERVALUEDSDMHF · OTC · Healthcare
SDMHF·OTC·Healthcare
UNDERVALUED
Sartorius Stedim Biotech S.A.
11.4%upside
MARKET PRICE
$181.00
FAIR PRICE
$201.60
MARGIN
$20.60
UNDERVALUEDFAIROVERVALUED
P/E RATIO
65.9x
DIV. YIELD
0.44%
ROE
6.6%
MARKET CAP
$15B
FPI
fairpriceindex.com

FAIR PRICE VALUATION

11.4%upside

Updated daily

Model: DCF 50% · Relative 30% · Consensus 20%

MARKET PRICE

$181.00

FAIR PRICE

$201.60

MARGIN

$20.60

UNDERVALUEDFAIROVERVALUED

P/E Ratio

65.9x

What is P/E? →

Div. Yield

0.44%

ROE

6.6%

Average

Market Cap

$15B

Large-cap

NOW AVAILABLE

Get notified when SDMHF's fair price changes

Push notifications when SDMHF's valuation shifts. Available on iOS and Android.

Download on the App StoreGet it on Google Play

FPI RATING

4.3/ 10

Strong profitability and stable earnings and revenue, but below-average fundamental quality and expensive valuation relative to fundamentals.

Analytical data, not an investment recommendation. Updated daily.

How we calculate this ↗

MARGIN OF SAFETY

A 20% margin of safety below fair value — the conservative entry level for risk-aware investors.

$161.28CONSERVATIVE ENTRY
$201.60FAIR PRICE
$181.00MARKET PRICE

SAFETY MARGIN

20%

Below fair value

ENTRY LEVEL

$161.28

Fair price × 0.80

DISTANCE

10.9%

Price to entry level

At the current price of $181.00, SDMHF trades 10.9% above the conservative entry level of $161.28. This entry level represents a 20% margin of safety below the calculated fair price of $201.60 — a buffer that accounts for estimation uncertainty in the valuation model.

Margin of safety is a risk management concept, not an investment recommendation. The 20% threshold follows Benjamin Graham's value investing framework. Fair price and entry levels are model-based estimates updated daily. Learn more about Margin of Safety ↗

VALUATION HISTORY

Loading chart data...

P/E RATIO HISTORY

Loading chart data...

METHODOLOGY

How we calculate SDMHF's fair price

Sartorius Stedim Biotech S.A.'s fair price of $201.60 is derived from a blended model that combines DCF analysis (50%), relative valuation against Healthcare peers using metrics like P/E and EV/EBITDA (30%), and analyst consensus (20%). At the current market price of $181.00, SDMHF trades 11.4% below its calculated fair value.

DCF MODEL · 50%

Discounted free cash flow analysis based on projected cash flows, discounted at a rate reflecting SDMHF's risk profile.

RELATIVE · 30%

Comparing SDMHF's valuation multiples against Healthcare peers to determine if the stock is over or undervalued relative to its industry.

ANALYST · 20%

Aggregated analyst price targets for SDMHF, weighted by recency and analyst accuracy.

TRY IT YOURSELF

Want to test your own assumptions? Use our free calculators to estimate SDMHF's fair value with your own inputs.

LEARN MORE

Bulios

POWERED BY BULIOS

Get full analysis, financials, and AI insights for SDMHF.

Explore on Bulios

FAQ

What is the fair price of SDMHF?+

Based on our blended model combining DCF analysis (50%), relative valuation against Healthcare peers (30%), and analyst consensus (20%), the fair price for Sartorius Stedim Biotech S.A. is $201.60. At the current market price of $181.00, SDMHF trades 11.4% below its calculated fair value.

Is SDMHF overvalued or undervalued?+

Sartorius Stedim Biotech S.A. is currently undervalued based on our valuation model. The stock trades at $181.00, which is 11.4% below the fair price of $201.60. The P/E ratio of 65.9x is a key metric in the valuation.

What is the margin of safety for SDMHF?+

With a 20% margin of safety applied to the fair price of $201.60, the conservative entry level for SDMHF is $161.28. At the current market price of $181.00, the stock trades 10.9% above this entry level. Margin of safety is a risk management concept from Benjamin Graham's value investing framework, not an investment recommendation.

How often is SDMHF's fair price updated?+

We update fair price calculations for SDMHF daily after market close. The current fair price of $201.60 incorporates the latest market data and sector multiples.

What factors affect SDMHF's fair price calculation?+

SDMHF's fair price of $201.60 is derived from DCF analysis (50% weight), relative valuation against Healthcare peers (30% weight), and analyst consensus (20% weight). Key metrics include P/E of 65.9x, ROE of 6.6%, and dividend yield of 0.44%.

Is SDMHF a good buy right now?+

At $181.00, SDMHF trades 11.4% below our fair value estimate of $201.60. The stock is currently undervalued. ROE stands at 6.6% (average). Fair Price Index provides valuation data — always do your own research before investing.

Does SDMHF pay dividends?+

SDMHF has a dividend yield of 0.44%.

RELATED STOCKS

Fair Price Index is for informational purposes only and does not constitute investment advice. Fair value calculations are model-based estimates and may not reflect actual market conditions. Always conduct your own research before making investment decisions.